Subscribe to RSS
DOI: 10.1055/s-0030-1253670
© Georg Thieme Verlag KG Stuttgart · New York
Vorhofflimmern – Zusammenhänge pathophysiologischer und therapeutischer Prinzipien
Atrial fibrillation – Links between principles of pathophysiology and treatmentPublication History
                     eingereicht: 13.9.2009
                     
                     akzeptiert: 14.1.2010
                     
Publication Date:
20 April 2010 (online)

Zusammenfassung
Vorhofflimmern (VHF) ist die häufigste anhaltende Herzrhythmusstörung, deren Grundlagen und klinische Forschung sich in stetigem Fluss befinden.
Ziel der vorliegenden Übersichtsarbeit ist es, dem nicht primär kardiologisch/elektrophysiologisch orientierten Arzt einen kurzen Überblick über die wichtigsten Konzepte der Pathophysiologie zu geben und über deren Einflüsse auf die Therapieprinzipien von VHF zu informieren. Vorgestellt werden die „Multiple Wavelet”-Theorie nach Moe und Allessie, das Konzept der ektopen Triggerung von paroxysmalem VHF nach Haissaguerre sowie die wichtigsten Mechanismen des atrialen Remodeling („atrial fibrillation begets atrial fibrillation” nach Wijffels) bei länger anhaltendem VHF. Die Bedeutung dieser pathophysiologischen Konzepte wird anschließend im Kontext der medikamentösen, rhythmuschirurgischen sowie katheterinterventionellen Therapieverfahren diskutiert. Gleichzeitig werden die Limitationen dieser Verfahren aufgrund pathophysiologischer Überlegungen skizziert.
Abstract
Atrial fibrillation is the most common supraventricular arrhythmia in humans, basic and clinical sciences are still developing. This present review aims to inform non-cardiologists respectively non-electrophysiologists about the most important pathophysiological concepts and their influence on therapeutical principles of atrial fibrillation. Moe’s and Allessie’s „multiple wavelet” theory is introduced as well as Haissaguerre’s concept of ectopic triggering of paroxysmal atrial fibrillation and the most important aspects of atrial remodeling („atrial fibrillation begets atrial fibrillation” according to Wijffels) during persistence of atrial fibrillation. Impact of these pathophysiological concepts is discussed within the context of medicamentous, surgical and interventional therapy. Concomitantly, limitations of these therapies due to pathophysiological considerations are delineated.
Schlüsselwörter
Vorhofflimmern - atriales Remodeling
Keywords
atrial fibrillation - atrial remodeling
Literatur
- 1 
            Allessie M, Ausma J, Schotten U. 
            Electrical, contractile and structural remodeling during atrial
            fibrillation. 
            Cardiovasc res. 
            2002; 
            54 
            230-246 
            
            Reference Ris Wihthout Link
- 2 
            Allessie M A, Boyden P A, Camm A J. et al .
            Pathophysiology and prevention
            of atrial fibrillation. 
            Circ J. 
            2001; 
            103 
            769-777 
            
            Reference Ris Wihthout Link
- 3 Allessie M A, Lammers W J, Bonke F I. et al .Experimental evaluation
            of Moe’s multiple wavelet hypothesis of atrial fibrillation. In: Cardiac Electrophysiology and Arrhythmias. NY: Grune&Stratton; 1985: 265-275 
            Reference Ris Wihthout Link
- 4 
            Benjamin E J, Chen P S, Bild D E. et al .
            Prevention of atrial fibrillation:
            report from a national heart, lung, and blood institute workshop. 
            Circ J. 
            2009; 
            119 
            606-618 
            
            Reference Ris Wihthout Link
- 5 
            Bosch R F, Scherer C R, Rub N. et al .
            Molecular mechanisms of early electrical
            remodeling: transcriptional downregulation of ion channel subunits
            reduces I (Ca,L) and I (to) in rapid atrial pacing in rabbits. 
            J Am Coll Cardiol. 
            2003; 
            41 
            858-869 
            
            Reference Ris Wihthout Link
- 6 
            Bosch R F, Zeng X, Grammer J B. et al .
            Ionic mechanisms of electrical remodeling
            in human atrial fibrillation. 
            Cardiovasc res. 
            1999; 
            44 
            121-131 
            
            Reference Ris Wihthout Link
- 7 
            Brodsky M A, Allen B J, Capparelli E V. et al .
            Factors determining maintenance
            of sinus rhythm after chronic atrial fibrillation with left atrial dilatation. 
            Am J Cardiol. 
            1989; 
            63 
            1065-1068 
            
            Reference Ris Wihthout Link
- 8 
            Calkins H, Brugada J, Packer D L. et al .
            HRS/EHRA/ECAS expert
            consensus statement on catheter and surgical ablation of atrial
            fibrillation: recommendations for personnel, policy, procedures
            and follow-up. A report of the Heart Rhythm Society (HRS) task force
            on catheter and surgical ablation of atrial fibrillation. 
            Heart
            Rhythm. 
            2007; 
            4 
            816-861 
            
            Reference Ris Wihthout Link
- 9 
            Cappato R, Calkins H, Chen S A. et al .
            Prevalence and causes of fatal outcome
            in catheter ablation of atrial fibrillation. 
            J Am Coll
            Cardiol. 
            2009; 
            53 
            1798-1803 
            
            Reference Ris Wihthout Link
- 10 
            Chen S A. 
            Catheter ablation of atrial fibrillation: fact and controversy. 
            J Cardiovasc Electrophysiol. 
            2002; 
            13 
            1074-1075 
            
            Reference Ris Wihthout Link
- 11 
            Cox J L. 
            Surgical treatment of atrial fibrillation: a review. 
            Europace. 
            2004; 
            5 Suppl 1 
            S20-29 
            
            Reference Ris Wihthout Link
- 12 
            Doll N, Fabricius A M, Gummert J F. et al .
            [Surgical treatment
            of therapy resistant atrial fibrillation]. 
            Z
            Kardiol. 
            2003; 
            92 
            712-720 
            
            Reference Ris Wihthout Link
- 13 
            Duray G Z, Ehrlich J R, Hohnloser S H. 
            Dronedarone: a novel antiarrhythmic agent
            for the treatment of atrial fibrillation. 
            Curr Opin Cardiol. 
            2010; 
            25 
            53-58 
            
            Reference Ris Wihthout Link
- 14 
            Eckstein J, Kuhne M, Osswald S, Schotten U. 
            Mapping of atrial fibrillation – basic
            research and clinical applications. 
            Swiss Med Wkly. 
            2009; 
            139 
            496-504 
            
            Reference Ris Wihthout Link
- 15 
            Einthoven W. 
            Le télécardiogramme. 
            Arch Int Physiol. 
            1906; 
            4 
            132-164 
            
            Reference Ris Wihthout Link
- 16 
            Fuster V, Ryden L E, Cannom D S. et al .
            ACC/AHA/ESC
            2006 guidelines for the management of patients with atrial fibrillation:
            full text: a report of the American College of Cardiology/American
            Heart Association task force on practice guidelines and the European
            Society of Cardiology Committee for Practice Guidelines (Writing
            Committee to Revise the 2001 guidelines for the management of patients
            with atrial fibrillation) developed in collaboration with the European Heart
            Rhythm Association and the Heart Rhythm Society. 
            Europace. 
            2006; 
            8 
            651-745 
            
            Reference Ris Wihthout Link
- 17 
            Goette A, Honeycutt C, Langberg J J. 
            Electrical remodeling in atrial fibrillation.
            Time course and mechanisms. 
            Circ J. 
            1996; 
            94 
            2968-2974 
            
            Reference Ris Wihthout Link
- 18 
            Haissaguerre M, Jais P, Shah D C. et al .
            Spontaneous initiation of atrial fibrillation
            by ectopic beats originating in the pulmonary veins. 
            N Engl
            J Med. 
            1998; 
            339 
            659-666 
            
            Reference Ris Wihthout Link
- 19 
            Jalife J, Berenfeld O, Mansour M. 
            Mother rotors and fibrillatory conduction: a mechanism of atrial
            fibrillation. 
            Cardiovasc res. 
            2002; 
            54 
            204-216 
            
            Reference Ris Wihthout Link
- 20 
            Jons C, Hansen P S, Johannessen A. et al .
            The medical antiarrhythmic treatment or
            radiofrequency ablation in paroxysmal atrial fibrillation (MANTRA-PAF)
            trial: clinical rationale, study design, and implementation. 
            Europace. 
            2009; 
            11 
            917-923 
            
            Reference Ris Wihthout Link
- 21 
            Le H euzey
            JY, Paziaud O, Piot O. et al .
            Cost of care distribution in atrial fibrillation
            patients: the COCAF study. 
            Am Heart J. 
            2004; 
            147 
            121-126 
            
            Reference Ris Wihthout Link
- 22 
            Lewalter T, Tebbenjohanns J, Wichter T. et al .
            Kommentar zu „ACC/AHA/ESC
            2006 Guidelines for the management of patients with atrial fibrillation – executive
            summary”. 
            Der Kardiologe. 
            2008; 
            2 
            24 
            
            Reference Ris Wihthout Link
- 23 Lewis T. The mechanism an graphic registration of the heart beat. 3rd
            ed. London: Shaw; 1925: 319-374 
            Reference Ris Wihthout Link
- 24 
            Matsuo S, Lellouche N, Wright M. et al .
            Clinical predictors of termination and
            clinical outcome of catheter ablation for persistent atrial fibrillation. 
            J Am Coll Cardiol. 
            2009; 
            54 
            788-795 
            
            Reference Ris Wihthout Link
- 25 
            Meinertz T, Willems S. 
            Treatment of atrial
            fibrillation in every days practice. 
            Der Internist. 
            2008; 
            49 
            1437-1442,
            1444 – 1435 
            
            Reference Ris Wihthout Link
- 26 
            Moe G K. 
            On the multiple wavelet hypothesis of atrial fibrillation. 
            Arch Int Pharmacodyn Ther. 
            1962; 
            140 
            183-188 
            
            Reference Ris Wihthout Link
- 27 
            Nademanee K, McKenzie J, Kosar E. et al .
            A new approach for catheter ablation of
            atrial fibrillation: mapping of the electrophysiologic substrate. 
            J Am Coll Cardiol. 
            2004; 
            43 
            2044-2053 
            
            Reference Ris Wihthout Link
- 28 
            Noheria A, Kumar A, Wylie Jr J V, Josephson M E. 
            Catheter ablation vs antiarrhythmic drug therapy for atrial
            fibrillation: a systematic review. 
            Arch Intern Med. 
            2008; 
            168 
            581-586 
            
            Reference Ris Wihthout Link
- 29 
            Ouyang F, Ernst S, Chun J. et
            al .
            Electrophysiological findings during ablation of
            persistent atrial fibrillation with electroanatomic mapping and
            double Lasso catheter technique. 
            Circ J. 
            2005; 
            112 
            3038-3048 
            
            Reference Ris Wihthout Link
- 30 
            Pappone C, Augello G, Sala S. et al .
            A randomized trial of circumferential pulmonary
            vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial
            fibrillation: the APAF Study. 
            J Am Coll Cardiol. 
            2006; 
            48 
            2340-2347 
            
            Reference Ris Wihthout Link
- 31 
            Perez-Lugones A, McMahon J T, Ratliff N B. et al .
            Evidence of specialized conduction
            cells in human pulmonary veins of patients with atrial fibrillation. 
            J Cardiovasc Electrophysiol. 
            2003; 
            14 
            803-809 
            
            Reference Ris Wihthout Link
- 32 
            Rockson S G, Albers G W. 
            Comparing the
            guidelines: anticoagulation therapy to optimize stroke prevention
            in patients with atrial fibrillation. 
            J Am Coll Cardiol. 
            2004; 
            43 
            929-935 
            
            Reference Ris Wihthout Link
- 33 
            Roy D, Talajic M, Nattel S. et
            al .
            Rhythm control versus rate control for atrial fibrillation
            and heart failure. 
            N Engl J Med. 
            2008; 
            358 
            2667-2677 
            
            Reference Ris Wihthout Link
- 34 
            Shen J, Bailey M S, Damiano Jr R J. 
            The surgical treatment of atrial
            fibrillation. 
            Heart Rhythm. 
            2009; 
            6 
            S45-50 
            
            Reference Ris Wihthout Link
- 35 
            Tan E S, Rienstra M, Wiesfeld A C. et al .
            Long-term outcome of the atrioventricular
            node ablation and pacemaker implantation for symptomatic refractory
            atrial fibrillation. 
            Europace. 
            2008; 
            10 
            412-418 
            
            Reference Ris Wihthout Link
- 36 
            Van Gelder I C, Hagens V E, Bosker H A. et al .
            A comparison of rate control
            and rhythm control in patients with recurrent persistent atrial
            fibrillation. 
            N Engl J Med. 
            2002; 
            347 
            1834-1840 
            
            Reference Ris Wihthout Link
- 37 
            Veenhuyzen G D, Knecht S, O’Neill M D. et al .
            Atrial tachycardias encountered
            during and after catheter ablation for atrial fibrillation: part
            I: classification, incidence, management. 
            Pacing Clin
            Electrophysiol. 
            2009; 
            32 
            393-398 
            
            Reference Ris Wihthout Link
- 38 
            Wang Z, Page P, Nattel S. 
            Mechanism
            of flecainide’s antiarrhythmic action in experimental atrial
            fibrillation. 
            Circ Res. 
            1992; 
            71 
            271-287 
            
            Reference Ris Wihthout Link
- 39 
            Wijffels M C, Kirchhof C J, Dorland R, Allessie M A. 
            Atrial fibrillation
            begets atrial fibrillation. A study in awake chronically instrumented goats. 
            Circ J. 
            1995; 
            92 
            1954-1968 
            
            Reference Ris Wihthout Link
- 40 
            Willems S, Hoffmann B, Steven D. et al .
            Catheter ablation for atrial fibrillation:
            clinically established or still an experimental method?. 
            Herz. 
            2008; 
            33 
            402-411 
            
            Reference Ris Wihthout Link
- 41 
            Wyse D G, Waldo A L, DiMarco J P. et al .
            A comparison of rate control and
            rhythm control in patients with atrial fibrillation. 
            N
            Engl J Med. 
            2002; 
            347 
            1825-1833 
            
            Reference Ris Wihthout Link
Dr. Roman Laszlo
         Abteilung für Kardiologie und Kreislauferkrankungen, Klinikum
         der Eberhard-Karls-Universität Tübingen
         
         Otfried
         Müller Str. 10
         
         72076 Tübingen
         
         Phone: 07071/29-82712
         
         Fax: 07071/29-5040
         
         Email: roman.laszlo@med.uni-tuebingen.de
         
         
 
     
      
    